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Background: Uridine diphosphate-glucuronosyltransferase (UGT) gene family is involved in the detoxification of
biomaterials and drugs in the liver. Among the UGT gene family members, only UGT1A1 is involved in bilirubin
conjugation. As a result, deficient UGT1A1 activity causes jaundice. One disease that is characterized by reduced
UGT1A1 activity is Gilbert’s syndrome. Two prevalent UGT1A1 polymorphisms responsible for Gilbert’s syndrome
have been identified: G71R in exon 1 and A(TA)7TAA in the TATA box of the promoter region. Recently, the G71R
polymorphism has been associated with breastfeeding jaundice and neonatal hyperbilirubinemia in term infants.
However, its association with jaundice in very low birth weight infants (VLBWIs) has never been reported.
Case presentation: The patient was a female born at 28 weeks, 4 days gestation with a birth weight of 1172 g. On
day 21, intense yellowing of the skin and eyes was noted, and the patient’s total bilirubin level was 23.7 mg/dL (her
direct bilirubin level was 2.1 mg/dL). Therefore, an exchange transfusion was conducted. She had neither blood
type incompatibility nor a family history of constitutional jaundice. Metabolic screens for amino and organic acids
were negative. No elevation of any of the examined antibody titers was noted, and no evidence of an inflammatory
reaction was observed. In addition, no hematological abnormalities were detected. The direct/indirect Coombs test,
irregular antibody test and red blood cell antibody dissociation test were all negative, and her thyroid function was
normal. We performed sequence analysis of the UGT1A1 gene after the patient’s parents provided written informed
consent. Exon 1 of the UGT1 gene on chromosome 2 was analyzed by direct sequencing. A heterozygous
substitution from G to A (211G→A: G71R) in base 211 was noted.
Conclusion: We speculated that this preterm infant with carrying the G71R polymorphism reduced UGT1A1 activity
and developed severe jaundice that was likely triggered by factors such as breast feeding and medications. The
polymorphism appears at some frequency among VLBWIs, which would necessitate adequate care of severe
jaundice even after the acute phase.
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Uridine diphosphate-glucuronosyltransferase (UGT) gene
family is involved in the detoxification of biomaterials
and drugs in the liver. Among the UGT gene family
members, only UGT1A1 is involved in bilirubin conjuga-
tion. As a result, deficient UGT1A1 activity causes jaun-
dice. One disease that is characterized by reduced
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drome have been identified: G71R in exon 1 and A(TA)
7TAA in the TATA box of the promoter region. Homo-
zygous and compound heterozygous mutations of these
genetic regions can result in severe jaundice, and hetero-
zygous mutations serve as a risk factor for the develop-
ment of jaundice [1]. Recently, the G71R polymorphism
has been associated with breastfeeding jaundice and neo-
natal hyperbilirubinemia in term infants [2-4]. However,
its association with jaundice in very low birth weight in-
fants (VLBWIs) has never been reported. In this article,
we report case study of a VLBWIs carrying the G71Rd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 1 Amount of breast milk. Breastfeeding commenced on day 3, and exclusive breastfeeding was achieved on day 10.
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was first noticed on day 21 after birth.
Case presentation
The patient was a female born at 28 weeks, 4 days gesta-
tion with a birth weight of 1172 g. The mother was 29
years old with a history of 1 prior pregnancy, which
ended in a spontaneous abortion. After 28 weeks and 3
days of pregnancy, the mother was hospitalized because
of genital bleeding and labor pains. The labor pains were
difficult to suppress, and the mother delivered a baby
transvaginally the following day. When the placenta was
checked macroscopically, the chorion and umbilical cord
facing the fetus were found to be edematous and yellow.
Pathologically, mild neutrophil infiltration of the amni-
otic membrane stroma was noted and was accompanied
by necrosis of the umbilical cord stroma and the pres-
ence of degenerative neutrophils.
The patient was intubated at birth and had Apgar
scores of 6 at 1 minute and 7 at 5 minutes. She re-
ceived surfactant on the day of birth. Elevated levels of
IgM in the umbilical blood (35 mg/dL) indicated an
infection, and the patient was administered antibiotics
for 5 days. Indomethacin administration led to the
closure of a patent ductus arteriosus by the second
day of life, and tube feeding (artificial milk) was initi-
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Figure 2 Clinical course of jaundice. On day 21, the total bilirubin
level was 23.7 mg/dL (the direct bilirubin level was 2.1 mg/dL), and the
exchange transfusion was performed.day 3, and exclusive breastfeeding was achieved on day
10 (Figure 1).
The patient’s total bilirubin (TB) level was 6.8 mg/dL
on day 2, and phototherapy was initiated for 12 hours.
On day 21, intense yellowing of the skin and eyes was
noted, and the patient’s TB level was 23.7 mg/dL (her
direct bilirubin level was 2.1 mg/dL) (Figure 2). There-
fore, an exchange transfusion was conducted in accord-
ance with the criteria reported by Kawase et al. [5]. She
had neither blood type incompatibility nor a family
history of constitutional jaundice. Metabolic screens for
amino and organic acids were negative. No elevation
of any of the examined antibody titers was noted, and
no evidence of an inflammatory reaction was ob-
served. In addition, no hematological abnormalities
were detected. The direct/indirect Coombs test, ir-
regular antibody test and red blood cell antibody dis-
sociation test were all negative, and her thyroid
function was normal. No typical bilirubin encephalop-
athy symptoms were observed, and serial head ultra-
sonography revealed no lesions during hospitalization.
The follow-up head magnetic resonance imaging was
normal at 2 months of age, and her auditory brain-
stem responses were normal at 5 months of age.
Within 1 year, the patient could walk and showed fa-
vorable growth and development.Figure 3 UGT1A1 gene analysis. A substitution at base 211 from
G to A (211G→A: G71R) in exon 1 of the bilirubin uridine
diphosphate-glucuronosyltransferase (UGT1A1) gene was observed
with a heterozygous pattern (↓).
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after the patient’s parents provided written informed
consent. Exon 1 of the UGT1 gene on chromosome 2
was analyzed by direct sequencing. A heterozygous sub-
stitution from G to A (211G→A: G71R) in base 211 was
noted (Figure 3).
Discussion
The G71R polymorphism, which is common in East
Asia, is a risk factor for hyperbilirubinemia [1,2] and has
been associated with an approximate 40% reduction of
UGT1A1 activity [6]. In term infants, UGT1A1 activity
has been reported to be approximately 1% of that ob-
served in adult values [7]. We speculated that the
UGT1A1 activity in the case of the infant reported here
(a VLBWI carrying the G71R polymorphism) was less
than 1% of the typical activity in term infants. This in-
fant with low UGT1A1 activity developed severe jaun-
dice that was likely triggered by factors such as breast
feeding [8] and medications.
Pregnanediol, which is present in maternal milk, is
known to reduce UGT1A1 activity [8]. In the current
case, the patient developed severe jaundice when her
consumption of maternal milk increased after the age of
3 weeks (Figure 1).
A pathological examination of the placenta revealed
slight neutrophil infiltration of the amniotic membrane
stroma, accompanied by umbilical cord stroma necrosis,
the appearance of degenerative neutrophils and elevated
umbilical blood levels of IgM, findings consistent with
intrauterine infection. Although severe jaundice devel-
oped on day 21 after birth in this infant, the involvement
of infection in the development of jaundice could not be
completely ruled out in this case.
The jaundice was severe enough to necessitate ex-
change transfusion. However, the patient never showed
the classical symptoms of nuclear jaundice (reduced
muscular tone, opisthotonus and spastic symptoms)
[9,10]. The head magnetic resonance imaging, which
was performed on day 60 after birth, revealed no abnor-
malities in any region of the brain, including the
pallidum [10]. The auditory brainstem responses test
conducted on day 172 after birth revealed bilateral re-
sponses and appropriate responses to sounds. Thus, the
patient exhibited favorable growth and development. Al-
though the patient has shown no signs of kernicterus to
date, we propose to continue careful follow-up [10].
The estimated frequency of the G71R gene poly-
morphism in Japan is 0.15, and Gilbert’s syndrome af-
fects 3-7% of the entire population. The polymorphism
appears at a similar frequency among VLBWIs, which
would necessitate adequate care of severe jaundice even
after the acute phase. This UGT1A1 mutation is known
to be related to diverse diseases and to elevate the risk ofjaundice and gallstones [4]. Because treatment with several
anti-cancer drugs (such as irinotecan hydrochloride) can
cause bone marrow suppression and severe diarrhea in
individuals with the G71R polymorphism, screening for
polymorphisms in this gene prior to starting such
treatments is authorized. In Japanese individuals with unex-
plained jaundice, a potential UGT1A1 mutation should be
considered in the differential diagnosis, and preterm infants
with this polymorphism may be at risk for late onset
hyperbilirubinemia.
Conclusion
We speculated that this preterm infant with carrying the
G71R polymorphism reduced UGT1A1 activity and
developed severe jaundice that was likely triggered by
factors such as breast feeding and medications. The
polymorphism appears at some frequency among VLBWIs,
which would necessitate adequate care of severe jaundice
even after the acute phase.
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